Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of philadelphia chromosome-negative cells in chronic myelogenous leukemia
- 15 June 1991
- Vol. 67 (12) , 2959-2965
- https://doi.org/10.1002/1097-0142(19910615)67:12<2959::aid-cncr2820671203>3.0.co;2-t
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic PhaseAnnals of Internal Medicine, 1988
- In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.Proceedings of the National Academy of Sciences, 1987
- The CML-Specific P210 bcr / abl Protein, Unlike v- abl , Does Not Transform NIH/3T3 FibroblastsScience, 1987
- Clinical investigation of human alpha interferon in chronic myelogenous leukemiaBlood, 1987
- Autografting in chronic granulocytic leukaemiaClinics in Haematology, 1986
- Cryopreserved peripheral blood cells functioning as autografts in patients with chronic granulocytic leukaemia in transformation.BMJ, 1979
- Chronic Granulocytic LeukemiaMedical Clinics of North America, 1976
- A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa StainingNature, 1973